MYH7 Mutations in Restrictive Cardiomyopathy
Genetic variations, particularly in the MYH7 gene, are significant risk factors for RCM progression and HTx. Genetic screening may guide early interventions, while fibrosis and MYH7 pathways offer potential therapeutic targets.
Authors
- Xiumeng Hua (ORCID: https://orcid.org/0009-0006-5424-8812)
- Han Mo (ORCID: https://orcid.org/0000-0002-5089-9638)
- Weiteng Wang (ORCID: https://orcid.org/0000-0001-6480-9325)
- Xiao Chen (ORCID: https://orcid.org/0000-0002-4438-5286)
- Qian Zhao (ORCID: https://orcid.org/0000-0001-5257-8283)
- Jiangping Song (ORCID: https://orcid.org/0000-0002-9488-7823)
- Yue Zhang (ORCID: https://orcid.org/0000-0003-1472-8935)
- Shun Liu (ORCID: https://orcid.org/0000-0002-1389-5929)
- Yiqi Zhao (ORCID: https://orcid.org/0000-0002-8799-8023)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101693
- Citations
- 3
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- China National Funds for Distinguished Young Scientists